So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, ...
Cardinal Health (CAH) upgraded to Buy after a 100%+ run—see FY26 guidance, acquisitions, and nuclear medicine catalysts, plus ...
Cardinal Health has updated its financial outlook for fiscal year 2026 non-GAAP diluted earnings per share (EPS) to at least ...
Zacks Investment Research on MSN
Cardinal Health (CAH) is a top-ranked value stock: Should you buy?
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common ...
Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail ...
The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.
If you are wondering whether Cardinal Health's share price still offers value after a strong run, this breakdown will help ...
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...
Jan 13 (Reuters) - Drug distributor Cardinal Health raised its 2026 profit forecast on Tuesday, driven by robust demand for ...
Cardinal Health, Inc. (NYSE:CAH) is one of the stocks from different market sectors that Jim Cramer commented on. Cramer ...
Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal Health's MSO platforms to ~3,000 ...
Adds over 750 providers to Cardinal Health's (CAH) multi-specialty MSO platform, The Specialty Alliance Joins with recent urology acquisitions to bolster The Specialty Alliance's leadership in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results